Valacyclovir
| Half-life bình thường | 3 |
|---|---|
| Half-life ESRD | 14 |
| Liều bình thường | Varies with indication |
| Chỉnh liều suy thận | Herpes labialis: CrCl ≥50: 2 gm q12h x2 doses CrCl 30-49: 1 gm q12h x2 doses CrCl 10-29: 500 mg q12h x2 doses CrCl <10: 500 mg x1 dose Genital herpes, initial episode: CrCl ≥50: 1 gm q12h CrCl 30-49: No dosage adjustment CrCl 10-29: 1 gm q24h CrCl <10: 500 mg q24h Genital herpes, recurrent episode: CrCl ≥50: 500 mg q12h CrCl 30-49: No dosage adjustment CrCl 10-29: 500 mg q24h CrCl <10: 500 mg q24h Genital herpes, suppression: CrCl ≥50: 1 gm q24h CrCl 30-49: No dosage adjustment CrCl 10-29: 500 mg q24h CrCl <10: 500 mg q24h Genital herpes, suppression, HIV-infected: CrCl ≥50: 500 mg q12h CrCl 30-49: No dosage adjustment CrCl 10-29: 500 mg q24h CrCl <10: 500 mg q24h Herpes zoster: CrCl ≥50: 1 gm q8h CrCl 30-49: 1 gm q12h CrCl 10-29: 1 gm q24h CrCl <10: 500 mg q24h |
| Hemodialysis | 500 mg q24h (AD on dialysis days) |
| CAPD | 500 mg q24h |
| CRRT | No data |
| SLED | No data |